Is Azurette 28 Day in shortage in 2026? Get the latest update on availability, pricing, and what patients can do to find their birth control.
If you've been struggling to fill your Azurette prescription, you're probably wondering: is there an official shortage? The short answer is that Azurette 28 Day is not currently listed on the FDA's official drug shortage database. But that doesn't mean it's easy to find.
Many patients report sporadic difficulty finding Azurette at their local pharmacies. The gap between "officially in shortage" and "practically impossible to find" is real — and frustrating. Here's what's actually going on with Azurette availability in 2026 and what you can do about it.
Yes. Azurette 28 Day is still an active, FDA-approved generic oral contraceptive. It has not been discontinued. However, Azurette is what's known as a niche generic — a medication with a relatively small market share compared to blockbuster generics. Only a handful of manufacturers produce it, which makes the supply more vulnerable to disruptions.
The original brand-name product, Mircette, was discontinued years ago. Azurette is one of several generic versions that remain on the market, along with Kariva, Viorele, Pimtrea, and Volnea.
Even without a formal shortage designation, several factors contribute to Azurette's spotty availability:
With only a small number of companies producing Azurette, any disruption — equipment maintenance, quality control issues, raw material delays — can quickly ripple through the supply chain. Generic oral contraceptives operate on thin profit margins, so manufacturers have little incentive to maintain large buffer inventories.
Major chain pharmacies typically stock only 1-2 generic versions of each oral contraceptive formulation. If your pharmacy carries Kariva instead of Azurette, they may not have Azurette available at all — even though it's not in shortage nationally. For a deeper dive, read why Azurette is so hard to find.
The pharmaceutical supply chain has faced ongoing stress in recent years due to raw material sourcing issues, international shipping disruptions, and increased demand for certain drug classes. While these pressures affect many medications, niche generics like Azurette feel the impact more acutely.
The cost of Azurette 28 Day varies significantly depending on how you pay:
If you're paying out of pocket, a discount card can save you up to 80% or more. See our full guide on how to save money on Azurette in 2026.
If Azurette remains hard to find in your area, you have several options:
Kariva, Viorele, Pimtrea, and Volnea all contain the same active ingredients (Desogestrel 0.15 mg / Ethinyl Estradiol 0.02 mg / 0.01 mg) in the same 21/2/5 regimen. Your pharmacist can often substitute one of these without a new prescription, depending on state laws and your doctor's instructions.
If none of the direct equivalents are available, Apri and Enskyce contain Desogestrel with a slightly higher estrogen dose (0.03 mg). Talk to your doctor about whether this switch makes sense for you.
Telehealth providers can prescribe Azurette or alternatives quickly and often send prescriptions directly to a pharmacy that has the medication in stock. Learn more about finding a doctor who can prescribe Azurette near you.
Here are the most effective steps you can take today:
For a complete walkthrough, see our guide on how to find Azurette in stock near you.
Azurette 28 Day is not officially in shortage and is not discontinued — but real-world availability can be inconsistent. The combination of limited manufacturers, pharmacy stocking choices, and supply chain pressures means you may need to be proactive about finding your medication.
Use Medfinder to check pharmacy stock in your area, explore equivalent alternatives with your doctor, and take advantage of discount programs to keep costs low. You deserve consistent access to your birth control — don't let supply chain issues get in the way.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
